Search Results

Refine search

News & Features

Beyond the primary patent: How pharma can build competitive barriers

A medicine reaching the end of its primary patent term does not necessarily mean the market is open to generics. The complex patent landscape surrounding semaglutide shows how secondary patents covering indications, formulations and manufacturing processes can extend competitive barriers—and why careful freedom-to-operate analysis is critical before launch, says Ana Neves of Inventa. 16 September 2026

Pharma

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

Reflecting on decades of patent searching experience, senior scientist on the CAS IP Services team, David Saari, offers insights into the importance of a multidisciplinary approach in today's competitive IP landscape. 12 August 2026

Pharma

Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany

Takanori Abe of Abe & Partners brings the perspective of a lawyer with first-hand experience in the German courtrooms to Pharmaceutical, Biological and Chemical Patents, a valuable resource on case law. 10 August 2026

Regulation & Industry

GLP-1 patents and Africa: The COVID-19 lessons we still have not learned

Weight loss drugs promise a diabetes breakthrough in Africa, but patent barriers stall access. What does COVID-19 tell us about how to solve the continent’s silent crisis? Asks Sofia Araújo of Inventa. 24 June 2026

Asia

IndiaMart v CDSCO: A test of intermediary liability

The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar. 31 March 2026

Biotech

An update on patenting in Ukraine, Russia and Eurasia

Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region. 2 September 2025

Americas

The right formula: Minimising the cost of chemical and pharma patents

From setting a clear overall strategy to drafting high-quality claims, Christopher Wheeler and Gerald Murphy of Birch, Stewart, Kolasch & Birch explain how to reduce patent prosecution expenditure and obtain better IP protection. 26 August 2025

Asia

Overcoming refusal of TMs containing ingredient names in China

Hui Zhuang of CCPIT Patent and Trademark Law Office discusses several strategies to increase the chance of pharmaceutical or food trademarks that include ingredients being registered. 21 August 2025

Africa

Explainer: ARIPO’s role in Plant Variety Protection

Africa’s agricultural future is imperative to life and prosperity in the region—and the Arusha Protocol gives breeders the protection they need, explains the African Regional Intellectual Property Organization. 15 July 2025

Africa

Commercialising genomic tech in Nigeria

Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola Tunmise-Ajani of Inventa International. 29 April 2025